
CAS 342026-92-0
:Sipoglitazar
Description:
Sipoglitazar is a synthetic compound classified as a thiazolidinedione, primarily developed for the treatment of type 2 diabetes. It functions as a dual agonist of peroxisome proliferator-activated receptors (PPARs), specifically PPAR-α and PPAR-γ, which play crucial roles in glucose and lipid metabolism. This dual action helps improve insulin sensitivity and regulate lipid profiles, making it beneficial for managing blood sugar levels and reducing cardiovascular risks associated with diabetes. Sipoglitazar has been noted for its potential to lower triglyceride levels and improve overall metabolic health. The compound is characterized by its unique chemical structure, which includes a thiazolidine ring, contributing to its biological activity. As with many pharmaceutical agents, its efficacy and safety profile are evaluated through clinical trials, and it may exhibit side effects typical of PPAR agonists, such as weight gain or fluid retention. Ongoing research continues to explore its full therapeutic potential and mechanisms of action in metabolic disorders.
Formula:C25H25N3O4S
Synonyms:- TAK 654
- TAK-654
- CS-1568
- TAK654
- 3-Ethoxy-1-[[4-[(2-phenyl-4-thiazolyl)Methoxy]phenyl]Methyl]-1H-pyrazole-4-propanoic Acid
- Sipoglitazar
- 3-[3-Ethoxy-1-[4-[(2-phenyl-1,3-thiazol-4-yl)Methoxy]benzyl]-1H-pyrazol-4-yl]propionic Acid
- 1H-Pyrazole-4-propanoic acid, 3-ethoxy-1-[[4-[(2-phenyl-4-thiazolyl)methoxy]phenyl]methyl]-
- 3-[3-Ethoxy-1-[4-(2-phenyl-4-thiazolylMethoxy)benzyl]-1H-pyrazol-4-yl]propionic Acid
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Sipoglitazar
CAS:Controlled Product<p>Applications Sipoglitazar is a novel antidiabetic agent. Sipoglitazar displays triple agonistic activities on the human peroxisome proliferator-activated receptors, hPPAR-γ, -α, and -δ.<br>References Nishihara, M. et al.: Drug Metab. Dispos., 40, 249 (2012);<br></p>Formula:C25H25N3O4SColor and Shape:White To Off-WhiteMolecular weight:463.55Sipoglitazar
CAS:<p>Sipoglitazar, a PPARγ agonist, is used potentially for the treatment of diabetes.</p>Formula:C25H25N3O4SPurity:98%Color and Shape:SolidMolecular weight:463.55

